Moleculin Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.12.24	Moleculin Evaluates Prelim. Activity Of Annamycin In Acute Ara-C, VEN Resistant Myeloid Leukemia (RTTNews)
14.08.24	Moleculin Biotech Inc Q2 Loss Declines (RTTNews)
10.04.24	Moleculin Biotech Reveals Positive Anti-cancer Data For Annamycin With Non-cardiotoxic Effects (RTTNews)
25.03.24	Moleculin Biotech Reports Positive Interim Data From MB-106 Phase 1B/2 Study In AML (RTTNews)
11.12.23	Moleculin Presents Preliminary Efficacy Data Of Annamycin In Acute Myeloid Leukemia (RTTNews)
13.11.23	Moleculin Biotech Announces Positive Interim Data For Annamycin Trials (RTTNews)
18.09.23	Moleculin Biotech Reports Independent Report Of No Cardiotoxicity In Annamycin (RTTNews)
13.02.23	Moleculin Biotech Reports Topline Data From European Phase 1 Trial Of Annamycin (RTTNews)
15.12.22	Moleculin: Final Cohort Of Phase 1 Single Agent Trial Of Annamycin Shows 80% Overall Response Rate (RTTNews)
07.12.22	Moleculin Announces FDA Fast Track Designation For WP1122 (RTTNews)
27.09.22	Moleculin Says WP1096 Molecule To Be Evaluated In NIAID-Funded Animal Studies (RTTNews)
06.09.22	Moleculin Biotech Announces Receipt Of Orphan Drug Designation For WP1122 - Quick Facts (RTTNews)
27.12.21	Moleculin : Interim Data Of Annamycin On Soft Tissue Sarcoma Lung Metastases Show Clinical Activity (RTTNews)
01.12.21	Moleculin: New IND Enables Parallel Development Of WP1122 As Cancer Therapy (RTTNews)
19.10.21	Moleculin Biotech Gets Authorization In The U.K. To Begin Phase 1a Trial Of WP1122 (RTTNews)
03.02.21	SAVA Jumps From $7 To $75 In Just 3 Weeks, DRRX Gets FDA Nod, IMVT Pauses Trials, OCGN Catches Eye (RTTNews)
02.02.21	Stock Alert: Moleculin Biotech Surges 70% (RTTNews)
22.01.21	Pre-market Movers In Healthcare Sector: ADMP, FLDM, ATOS, AUPH, SENS... (RTTNews)
11.01.21	Pre-market Movers In Healthcare Sector: TRXC, JAGX, ALRN, BNGO, MBRX, APDN… (RTTNews)
29.12.20	Moleculin Stock Rises After FDA Grants Annamycin Orphan Drug Designation For Soft Tissue Sarcomas (RTTNews)
02.12.20	Pre-market Movers In Healthcare Sector: ZOM, BNTX, PFE, MESO, OVID… (RTTNews)
14.09.20	Moleculin : COVID-19 In Vivo Testing Contracted For WP1122 (RTTNews)
21.07.20	Moleculin Biotech: Second Lab Testing Confirms WP1122 Antiviral Activity Against Coronavirus (RTTNews)
17.07.20	Pre-market Movers In Healthcare Sector: BNGO, ACRX, NBRV, HTBX... (RTTNews)
15.07.20	Stock Alert: Moleculin Shares Up 38% In Premarket On Production Deal For COVID-19 Candidate WP1122 (RTTNews)
09.04.20	BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19 (RTTNews)
08.04.20	Stock Alert: Moleculin Biotech Soars 165% On Potential Treatment For COVID-19 (RTTNews)
11.07.18	Will This News Move This Stock? (RTTNews)
16.02.18	FDA To Decide On APRI's ED Drug, KURA Nails It, MBRX Dynamic, GLMD Awaits ARREST (RTTNews)
07.12.17	MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today (RTTNews)
13.09.17	Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs (PR Newswire)
13.09.17	Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs (PR Newswire)
06.09.17	Biotech Stocks Move Higher on New Clinical Trial Developments and Ground-breaking Collaborations (PR Newswire)
06.09.17	Biotech Stocks Move Higher on New Clinical Trial Developments and Ground-breaking Collaborations (PR Newswire)
06.09.17	Technical Reports on Biotech Equities -- Celgene, Dynavax Technologies, Keryx Biopharma, and Moleculin Biotech (PR Newswire)
30.08.17	APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision (RTTNews)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
22.08.17	Clinical and Regulatory Progress Boosting Biotech Sector (PR Newswire)
22.08.17	Clinical and Regulatory Progress Boosting Biotech Sector (PR Newswire)
16.08.17	Biotech Sector Rises on Accelerated Anti-cancer Drug Candidate Developments and Clinical Trial Progress (PR Newswire)
16.08.17	Biotech Sector Rises on Accelerated Anti-cancer Drug Candidate Developments and Clinical Trial Progress (PR Newswire)
09.08.17	Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector (PR Newswire)
09.08.17	Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector (PR Newswire)
03.08.17	Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run (PR Newswire)
03.08.17	Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run (PR Newswire)
02.08.17	Breakfast Technical Briefing on Biotech Stocks -- Dynavax Technologies, Keryx Biopharma, La Jolla Pharma, and Moleculin Biotech (PR Newswire)
25.07.17	Biotech Sector Continued Resurgence Fueled by Increasing Clinical Trial Activity & Business Friendly FDA Leadership (PR Newswire)
25.07.17	Biotech Sector Continued Resurgence Fueled by Increasing Clinical Trial Activity & Business Friendly FDA Leadership (PR Newswire)
18.07.17	Biotech Stocks Growing Faster Than Other Sectors Fueled by Breakthroughs in R&D and Clinical Trials (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	133.55	4.50 %	K V
Swiss Life Hldg	693.60	0.93 %	K V
Zurich Insur Gr	552.80	0.91 %	K V
Kuehne+Nagel Int	206.60	0.78 %	K V
Sonova Hldg	294.00	0.58 %	K V
Sika	228.20	-1.04 %	K V
Part Grp Hldg	1’264.50	-1.56 %	K V
Geberit	538.20	-1.61 %	K V
Alcon	75.22	-1.75 %	K V
Lonza Grp	532.80	-2.81 %	K V

Nachrichten zu Moleculin Biotech Inc

Aktien Top/Flop

Meistgelesene Nachrichten